Developing gene therapy for TOMT-linked hearing loss
In this project, Dr Christopher Cunningham and Dr Adele Moatti at the University of Pittsburgh, USA, are developing a gene therapy as a method to treat hearing loss caused by mutations in the TOMT gene. Project start date: March 2026 Project end date: February 2028 About the proj
DeafMonitor aggregates Deaf-community news and credits every story to its original publisher. This story was reported by RNID.
Read the full story at RNID
Read the full story at RNID